- Vulnerable plaque
A vulnerable plaque is an
atheromatous plaque, an unstable collection of white blood cells (primarily macrophages) and lipids(including cholesterol) in the wall of an arterywhich is particularly prone to produce sudden major problems, such as a heart attack or stroke.
In many cases, a vulnerable plaque has a thin
fibrous capand a large and soft lipid pool underlying the cap. These characteristics together with the usual hemodynamic pulsating expansion during systoleand elastic recoil contraction during diastolecontribute to a high mechanical stress zone on the fibrous capof the atheroma, making it prone to rupture. Increased hemodynamic stress correlates with increased rates of major cardiovascular events associated with exercise, especially exercise beyond levels the individual does routinely.
atheromabecomes vulnerable if it grows more rapidly and has a thin cover separating it from the bloodstream inside the arterial lumen. Tearing of the cover is called "plaque rupture".
atheromarupture and healing is one of the mechanisms, perhaps the dominant one, which creates artery stenosis.
Researchers have found that inflammation in the arteries leads to the development of "soft" or vulnerable plaque, which when released aggressively promotes blood clotting.
Researchers now think that vulnerable plaque, see
atherosclerosisis formed in the following way: [ [http://www.texasheartinstitute.org/HIC/Topics/Cond/vulplaq.cfm Texas Heart Institute, Heart Information Center] ]
Lipoproteinparticles, which carry fats and cholesterol in the blood stream, are absorbed by the artery wall, past the endotheliumlining, cholesterol is released and then oxidized. This process typically starts in childhood.
* Oxidized cholesterol is an irritant which causes the release of proteins (called
* The cytokines make the artery wall sticky, which attracts immune-system white blood cells (specifically
* The monocytes squeeze into the artery wall. Once inside, they transform into eating cells called
macrophagesand ingest the oxidized cholesterol droplets.
* The macrophages sometimes become so cholesterol and membrane laden that they die in place, releasing their fat laden membranes into the intracellular space. This attracts more macrophages.
* In some regions of increased macrophage activity, macrophage-induced-enzymes erode away the fibrous membrane beneath the endothelium so that the cover separating the plaque from blood flow in the
lumenbecomes thin and fragile.
* Mechanical stretching and contraction of the artery, with each heart beat, results in rupture of the thin covering membrane spewing clot-promoting plaque contents into the blood stream.
When this inflammation is combined with other stresses, such as high blood pressure (increased mechanical stretching and contraction of the arteries with each heart beat), it can cause the thin covering over the plaque to split, spilling the contents of the vulnerable plaque into the bloodstream. The sticky cytokines on the artery wall capture blood cells (mainly
platelets) that accumulate at the site of injury. When these cells clump together, they form a clot, sometimes large enough to block the artery.
The most frequent cause of a cardiac event following rupture of a vulnerable plaque is blood clotting on top of the site of the ruptured plaque that blocks the lumen of the
artery, thereby stopping blood flow to the tissues the arterysupplies.
Upon rupture, atheroma tissue debris may spill into the blood stream; this debris is often too large (over 5 micrometers) to pass on through the capillaries downstream. In this, the usual situation, the debris obstruct smaller downstream branches of the artery resulting in temporary to permanent end artery/capillary closure with loss of blood supply to, and death of the previously supplied tissues. A severe case of this can be seen during
angioplastyin the slow clearance of injected contrast down the artery lumen. This situation is often termed non-reflow.
atheromarupture may allow bleeding from the lumen into the inner tissue of the atheromamaking the atheroma size suddenly increase and protrude into the lumen of the artery producing lumen narrowing or even total obstruction.
While a single ruptured plaque can be identified during autopsy as the cause of a coronary event, there is currently no way to identify a culprit lesion before it ruptures. Because artery walls typically enlarge in response to enlarging plaques, these plaques do not usually produce much
stenosisof the artery lumen. Therefore, they are not detected by cardiac stress testsor angiography, the tests most commonly performed clinically with the goal of predicting susceptibility to future heart attack. Additionally, because these lesions do not produce significant stenoses, they are typically not considered "critical" and/or interventionable by interventional cardiologists, even though research indications they are the more important lesions for producing heart attacks.
The tests most commonly performed clinically with the goal of testing susceptibility to future heart attack include several medical research efforts, starting in the early to mid-1990s, using intravascular ultrasound
IVUS), thermography,(near-infrared spectroscopy) careful clinical follow-up and other methods, to predict these lesions and the individuals most prone to future heart attacks. These efforts remain largely research with no useful clinical methods to date (2006).
Another approach to detecting and understanding plaque behavior, used in research and by a few clinicians, is to use ultrasound to non-invasively measure wall thickness (usually abbreviated IMT) in portions of larger arteries closest to the skin, such as the carotid or femoral arteries. While stability vs. vulnerability cannot be readily distinguished in this way, quantitative baseline measurements of the thickest portions of the arterial wall (locations with the most plaque accumulation). Documenting the IMT, location of each measurement and plaque size, a basis for tracking and partially verifying the effects of medical treatments on the progression, stability or potential regression of plaque, within a given individual over time, may be achieved.
Patients can lower their risk for vulnerable plaque rupture in the same ways that they can cut their heart attack risk: take aspirin, eat a proper diet, quit smoking, and begin an exercise program. Researchers also think that obesity and diabetes may be tied to high levels of C-reactive protein. [ [http://www.texasheartinstitute.org/HIC/Topics/Cond/vulplaq.cfm Texas Heart Institute, Heart Information Center] ]
No clinically validated detection or treatment methods for vulnerable plaque exist currently. [Heart Disease and Stroke Statistics – 2006 update, American Heart Association.]
Newer clinical trial results (2007), e.g. the COURAGE trial,cite journal |author=Boden WE, O'Rourke RA, Teo KK, "et al" |title=Optimal medical therapy with or without PCI for stable coronary disease |journal=N. Engl. J. Med. |volume=356 |issue=15 |pages=1503–16 |year=2007 |month=April |pmid=17387127 |doi=10.1056/NEJMoa070829 |url=http://content.nejm.org/cgi/content/full/356/15/1503] have demonstrated that aggressively treating some of the physiologic behavioral factors which promote atheromas with "optimal medical therapy" (not opening stenoses, per-se) produced the most effective results in terms of improving human survival and quality of life for those who have been identified as having already developed advanced cardiovascular disease with many vulnerable plaques.
Wikimedia Foundation. 2010.
См. также в других словарях:
Atherosclerosis — For the journal, see Atherosclerosis (journal). Atherosclerosis Classification and external resources The progression of atherosclerosis (size exaggerated; see text) ICD 10 … Wikipedia
Atheroma — Classification and external resources Atherosclerotic plaque from a carotid endarterectomy specimen. This shows the bifurcation of the common into the internal and … Wikipedia
Intravascular ultrasound — (IVUS) is a medical imaging methodology using a specially designed catheter with a miniaturized ultrasound probe attached to the distal end of the catheter. The proximal end of the catheter is attached to computerized ultrasound equipment. It… … Wikipedia
Phytosterol — Phytosterols (also called plant sterols) are a group of steroid alcohols, phytochemicals naturally occurring in plants. They are white powders with mild, characteristic odor, insoluble in water and soluble in alcohols. They have many applications … Wikipedia
Kevin Kimberlin — [http://www.kevinkimberlin.com/ Kevin Kimberlin] is chairman of the venture capital firm, [https://www.spencertrask.com/index.aspx Spencer Trask Co.] , and a founder of several breakthrough companies in technology and healthcare. [… … Wikipedia
ABHD2 — Abhydrolase domain containing 2, also known as ABHD2, is a human gene.cite web | title = Entrez Gene: ABHD2 abhydrolase domain containing 2| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene Cmd=ShowDetailView TermToSearch=11057| accessdate … Wikipedia
Gommose — Plaque de gomme La gommose est une maladie de certains arbres notamment ceux appartenant au genre Prunus (cerisiers, pruniers, abricotiers et pêchers) et quelques autres, comme les agrumes. Le symptôme de production de gomme (ou… … Wikipédia en Français
nutritional disease — Introduction any of the nutrient related diseases and conditions that cause illness in humans. They may include deficiencies or excesses in the diet, obesity and eating disorders, and chronic diseases such as cardiovascular disease,… … Universalium
Dental caries — This article is about dental caries in humans. To read about dental caries in other animals, please see dental caries (non human). Dental caries Classification and external resources Destruction of a tooth by cervical decay from dental caries.… … Wikipedia
sensible — [ sɑ̃sibl ] adj. • XIIIe; lat. sensibilis « qui peut être senti »; « qui peut sentir », en lat. médiéval I ♦ Sens actif 1 ♦ Capable de sensation et de perception. Les êtres sensibles. « Avoir l ouïe sensible, fine et juste » (Rousseau). « si le… … Encyclopédie Universelle